Catherine Eckford

The CHMP recommended approval of a variety of new medicines, including several treatments for hereditary and rare conditions.

The proposed method holds value for real-time monitoring of airborne bacteria with high sensitivity and rapid results, the study shows.

Preparing for a new era in the rare disease sector

Developed under MSL the gene therapy could provide a novel treatment option for paediatric patients at the earliest stage of the eye disease.

The method provides potential for sustainable use of nanomaterials and unique benefits compared to other spectrofluorimetric methods.

New data suggests that once-weekly prophylaxis treatment could provide an efficient and convenient option to treat haemophilia A in children.

The monoclonal antibody treatment is now approved in the US for both diabetic macular oedema and wet, or neovascular AMD.

In its January meeting, the EMA’s human medicines committee recommended eight new medicines, including biosimilars and a new vaccine.

The committee’s approval of the one-time gene therapy means the healthcare inequalities in sickle cell disease can begin to be re-addressed.

The spectroscopy-based study highlights the importance of integrating data-driven approaches to enhance isomer discrimination.